Related Experiment Video
Updated: May 23, 2026
06:37
Pluripotent Stem Cell Derived Cardiac Cells for Myocardial Repair
Published on: February 3, 2017
Induced pluripotent stem cells in cardiovascular research
Daniel Sinnecker1, Ralf J Dirschinger, Alexander Goedel
1Klinikum rechts der Isar - Technische Universität München, I. Medizinische Klinik - Kardiologie, Ismaninger Strasse 22, 81675, Munich, Germany. sinnecker@tum.de
Reviews of Physiology, Biochemistry and Pharmacology
|March 27, 2012
Summary
Induced pluripotent stem cells (iPSC) offer new cardiovascular research avenues. Patient-specific iPSC lines enable disease modeling and drug screening for heart conditions.
Area of Science:
- Stem Cell Biology
- Cardiovascular Research
- Regenerative Medicine
Background:
- Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSC) via transcription factor overexpression.
- iPSC technology presents significant potential for preclinical and clinical cardiovascular research.
Purpose of the Study:
- To explore the applications of iPSC in cardiovascular research, focusing on disease modeling, drug screening, and cell therapy.
- To highlight the advancements and challenges in utilizing iPSC for cardiovascular applications.
Main Methods:
- Deriving patient-specific iPSC lines from individuals with heritable cardiovascular diseases.
- Differentiating iPSC into relevant cardiovascular cell types for disease modeling.
- Utilizing iPSC-derived cells for drug screening and potential cell therapy.
Main Results:
- Successful modeling of heart rhythm disorders like Long-QT syndrome and catecholaminergic polymorphic ventricular tachycardia using patient-specific iPSC.
- Demonstrated potential for iPSC-derived cells in screening cardiovascular drugs and identifying adverse effects.
- Identified biological safety as a critical hurdle for iPSC-based cardiovascular cell therapy.
Conclusions:
- Patient-specific iPSC are a powerful tool for modeling cardiovascular diseases and advancing personalized medicine.
- iPSC technology holds promise for drug discovery and development in cardiology.
- Further research is necessary to ensure the safety and efficacy of iPSC for cardiovascular cell therapy.
More Related Videos
Related Concept Videos
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:06Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Somatic cells are...
01:13Induced Pluripotent Stem Cells
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
01:21EPS and iPS Cells in Disease Research
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
01:22iPS Cell Differentiation
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
01:17Stem Cell Culture
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...